Kalamazoo, Michigan, United States In 2003 was created Apjohn ventures, which is appeared as VC. The main department of described VC is located in the Kalamazoo. The venture was found in North America in United States.
The current fund was established by Donald Parfet, Mina Patel Sooch. The overall number of key employees were 6.
We can highlight the next thriving fund investment areas, such as Therapeutics, Medical. The fund has specific favorite in a number of founders of portfolio startups. Among the most popular portfolio startups of the fund, we may highlight CytoPherx, Svelte Medical Systems, Asterand. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - United States.
Speaking about the real fund results, this VC is 13 percentage points less often commits exit comparing to other organizations. The fund is constantly included in less than 2 deals per year. The usual things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2015. The high activity for fund was in 2009. Opposing the other organizations, this Apjohn ventures works on 16 percentage points less the average amount of lead investments.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Apjohn ventures, startups are often financed by Lurie Investment Fund, Grand Angels, Biosciences Research and Commercialization Center (BRCC). The meaningful sponsors for the fund in investment in the same round are Lurie Investment Fund, North Coast Technology Investors, Fort Washington Capital Partners Group. In the next rounds fund is usually obtained by Lurie Investment Fund, Capital Midwest Fund, Orchard Venture Partners.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Beijing Zhangshang Tong Wangluo Jishu Co., Ltd. | Beijing, Beijing, China |
| Consonance Capital Partners | New York, New York, United States |
| East West Capital Limited | Australia, New South Wales, Sydney |
| GL Capital | China, Shanghai |
| Gratitude Railroad | Park City, United States, Utah |
| Inventures | California, San Ramon, United States |
| iVisionary Ventures | Kentucky, Lexington, United States |
| Kora Healthcare | - |
| Party City | Elmsford, New York, United States |
| Resolute Venture Partners | Brentwood, Tennessee, United States |
| Resolute Ventures | California, San Francisco, United States |
| seedchange | California, San Francisco, United States |
| Starboard Value | New York, New York, United States |
| T3 | California, San Francisco, United States |
| Technion Seed | Hefa, Hefa, Israel |
| Telligent Capital Management | China, Hong Kong, Hong Kong Island |
| U.S. Global Investors | San Antonio, Texas, United States |
| United States Agency for International Development | District of Columbia, United States, Washington |
| Yield10 Bioscience | Massachusetts, United States, Woburn |
Discover 5 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Tetra Therapeutics | $5M | 29 Nov 2016 | Grand Rapids, Michigan, United States | ||
CytoPherx | $34M | 04 Jan 2012 | Ann Arbor, Michigan, United States | ||
CytoPherx | $11M | 17 Jun 2010 | Ann Arbor, Michigan, United States | ||
Intranasal Therapeutics | $18M | 30 Mar 2009 | New Jersey, United States | ||
CytoPherx | $2M | 22 Oct 2007 | Ann Arbor, Michigan, United States | ||
Intranasal Therapeutics | $39M | 15 Aug 2006 | New Jersey, United States | ||
Kereos | $19M | 20 Sep 2005 | City of Saint Louis, Missouri, United States | ||
Zystor | $8M | 16 Dec 2004 | Milwaukee, Wisconsin, United States | ||
Asterand | $3M | 26 Nov 2003 | Detroit, Michigan, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Tetra Therapeutics | $5M | 29 Nov 2016 | Grand Rapids, Michigan, United States | ||
CytoPherx | $34M | 04 Jan 2012 | Ann Arbor, Michigan, United States | ||
CytoPherx | $11M | 17 Jun 2010 | Ann Arbor, Michigan, United States | ||
Intranasal Therapeutics | $18M | 30 Mar 2009 | New Jersey, United States | ||
CytoPherx | $2M | 22 Oct 2007 | Ann Arbor, Michigan, United States | ||
Intranasal Therapeutics | $39M | 15 Aug 2006 | New Jersey, United States | ||
Kereos | $19M | 20 Sep 2005 | City of Saint Louis, Missouri, United States | ||
Zystor | $8M | 16 Dec 2004 | Milwaukee, Wisconsin, United States | ||
Asterand | $3M | 26 Nov 2003 | Detroit, Michigan, United States |
